Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Janni Christensen"'
Autor:
Anthony N. Hodder, Janni Christensen, Stephen Scally, Tony Triglia, Anna Ngo, Richard W. Birkinshaw, Brodie Bailey, Paola Favuzza, Melanie H. Dietrich, Wai-Hong Tham, Peter E. Czabotar, Kym Lowes, Zhuyan Guo, Nicholas Murgolo, Manuel de Lera Ruiz, John A. McCauley, Brad E. Sleebs, David Olsen, Alan F. Cowman
Publikováno v:
Structure (London, England : 1993). 30(7)
Plasmepsins IX (PMIX) and X (PMX) are essential aspartyl proteases for Plasmodium spp. egress, invasion, and development. WM4 and WM382 inhibit PMIX and PMX in Plasmodium falciparum and P. vivax. WM4 inhibits PMX, while WM382 is a dual inhibitor of P
Autor:
Alan Cowman, Anthony Hodder, Janni Christensen, Stephen Scally, Tony Triglia, Anna Ngo, Richard Birkinshaw, Brodie Bailey, Paola Favuzza, Melanie Dietrich, Wai-Hong Tham, Peter Czabotar, Kym Lowes, Zhuyan Guo, Nicholas Murgolo, Manuel Ruiz, John McCauley, Brad Sleebs, David Olsen
Plasmepsin IX (PMIX) and X (PMX) are aspartyl proteases of Plasmodium spp. that play essential roles in parasite egress, invasion and development. Consequently, they are important drug targets for Plasmodium falciparum and P. vivax. WM4 and WM382 are
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::da25abceb2f5e920a88acdacb60f0535
https://doi.org/10.21203/rs.3.rs-944781/v2
https://doi.org/10.21203/rs.3.rs-944781/v2
Autor:
Janni Christensen, Wai-Hong Tham, David B. Olsen, Alan F. Cowman, Anthony N. Hodder, Brodie L Bailey, Peter E. Czabotar, Brad E. Sleebs, Zhuyan Guo, Tony Triglia, Stephen Scally, Nicholas Murgolo, John A. Mccauley, Anna Ngo, Richard W Birkinshaw, Paola Favuzza, Kym N Lowes, Melanie H. Dietrich, Manuel de Lera Ruiz
Plasmepsin IX (PMIX) and X (PMX) are aspartyl proteases of Plasmodium spp. that play essential roles in parasite egress, invasion and development. Consequently, they are important drug targets for Plasmodium falciparum and P. vivax. WM4 and WM382 are
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4126c0504badacc5c905ca219c0808af
https://doi.org/10.21203/rs.3.rs-944781/v1
https://doi.org/10.21203/rs.3.rs-944781/v1
Autor:
Anthony Hodder, Janni Christensen, Stephen Scally, Tony Triglia, Anna Ngo, Richard Birkinshaw, Brodie L Bailey, Paola Favuzza, Melanie Dietrich, Wai-Hong Tham, Peter Czabotar, Kym Lowes, Zhuyan Guo, Nicholas Murgolo, Manuel de Lera Ruiz, John McCauley, Brad Sleebs, David Olsen, Alan Cowman
Publikováno v:
SSRN Electronic Journal.
Autor:
Janni Christensen, David B. Olsen, Kitsanapong Reaksudsan, Jennifer K. Thompson, Kai-Yuan Guo, Wai-Hong Tham, Tony Triglia, Christopher W. Boyce, Justin A Boddey, Lianyun Zhao, Nicholas Murgolo, Marissa Vavrek, Tanweer A. Khan, Alan F. Cowman, Helene Jousset Sabroux, Jocelyn Sietsma Penington, Ryan W.J. Steel, Manuel de Lera Ruiz, Brad E. Sleebs, Jonathan A. Robbins, Zhuyan Guo, Matthias Rottmann, Paola Favuzza, Anna Ngo, Lachlan Richardson, Julie Healer, John A. Mccauley, Kate E. Jarman, Sash Lopaticki, Tony Papenfuss, Melanie H. Dietrich, Mengwei Hu
Publikováno v:
Cell Host & Microbe
Summary Artemisin combination therapy (ACT) is the main treatment option for malaria, which is caused by the intracellular parasite Plasmodium. However, increased resistance to ACT highlights the importance of finding new drugs. Recently, the asparti